Cargando…
Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider
An estimated one million individuals in the US are diagnosed with herpes zoster (HZ; shingles) each year. Approximately 20% of these patients will develop postherpetic neuralgia (PHN), a complex HZ complication characterized by neuropathic pain isolated to the dermatome that was affected by the HZ v...
Autores principales: | Massengill, Jamie S, Kittredge, John L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956687/ https://www.ncbi.nlm.nih.gov/pubmed/24648752 http://dx.doi.org/10.2147/JPR.S57242 |
Ejemplares similares
-
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment
por: Jeon, Young Hoon
Publicado: (2015) -
Postherpetic Neuralgia and Trigeminal Neuralgia
por: Feller, L., et al.
Publicado: (2017) -
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology
por: Mallick-Searle, Theresa, et al.
Publicado: (2016) -
Postherpetic neuralgia in the elderly
por: Johnson, R W, et al.
Publicado: (2009) -
Treatment of postherpetic neuralgia: focus on pregabalin
por: Cappuzzo, Kimberly A
Publicado: (2009)